Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AIMthis companyAIM ImmunoTech Inc.	$0.16	-0.13×	-0.19×	20.78×	-0.45×	-2271.9%	-284.1%	-11961.4%	-15861.4%	142.7%	-313.6%	-619.7%	-0.5×	-0.31×	-12.96×	0.53×	0.0%	3	-51.36	2	C
ENSCEnsysce Biosciences, Inc.	$0.36	-0.23×	0.73×	0×	0.16×	-85.7%	0.0%	0.0%	0.0%	-316.6%	-320.9%	-337.1%	0.1×	0.39×	-545.69×	1.59×	0.0%	3	-82.13	2	C+
KALAKALA BIO, Inc.	$0.17	-0.17×	0.65×	0×	0.13×	24209.1%	0.0%	0.0%	0.0%	-385.6%	-559.8%	-706.1%	0×	0.32×	-11.95×	3.81×	0.0%	3	-92.87	2	B-
KTTAPasithea Therapeutics Corp.	$0.61	-0.44×	0.16×	0×	2.28×	2031.8%	0.0%	0.0%	0.0%	-37.0%	-37.7%	-167.7%	0×	2.73×	0×	11.35×	0.0%	2	1.38	2	B-
OGENOragenics, Inc.	$0.36	-0.17×	0.2×	0×	-0×	319.2%	0.0%	0.0%	0.0%	-118.9%	-108.5%	-547310.7%	0.03×	-0.01×	-11.91×	5.64×	0.0%	1	-63.79	2	C+
QNRXQuoin Pharmaceuticals, Ltd.	$3.86	-1.36×	1.65×	0×	241.74×	63270.6%	0.0%	0.0%	0.0%	-120.5%	-109.7%	-62.6%	0×	243.12×	0×	3.61×	0.0%	1	-13.64	2	C+
Peer median	—	-0.23×	0.65×	0×	0.16×	2031.8%	0.0%	0.0%	0.0%	-120.5%	-109.7%	-337.1%	0×	0.39×	-11.91×	3.81×	0.0%	2	-63.79	2	—